Navigation Links
Premier Research Announces Completion of Management Buyout
Date:6/10/2008

LONDON, June 10 /PRNewswire/ -- Premier Research Group plc, the international pharmaceutical services company, announces the completion of its previously announced management buyout. As a result, the company is no longer listed on the AIM market of the London Stock Exchange. The UK-based private equity firm ECI Partners provided funding for the transaction.

Said Dr. Simon Yaxley, Chief Executive Officer of Premier Research Group, "This event ensures that we are able to continue our thoughtful and measured 'buy-and-build' strategy to allow us to continue to deliver exceptional quality and service to our clients around the world." Dr. Yaxley continued, "Further, we are pleased to announce that our existing management team remains fully intact, and is as dedicated as ever to ensuring our clients' expectations are met or exceeded. As a result, our clients, both existing and prospective, will not experience any visible change in working with the Premier Research team."

Mr. Richard Chapman of ECI Partners commented, "We are extremely pleased to have concluded this important transaction. We have long been interested in the CRO sector, and are excited to have found a successful and growing company such as Premier Research in which to invest. Our comprehensive due diligence confirmed our belief that Premier Research is a company of the highest quality with an exceptional future in providing clinical research services to global pharmaceutical, biotechnology, and medical device companies. We are also pleased that the existing management team remains committed to the long-term success of the business."

About Premier Research

Premier Research is a leading solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for Analgesia, CNS, Infectious Disease, and Oncology and have a wealth of experience in medical device and pediatric research.

Premier Research has 30 offices and operates in more than 30 countries across Europe and North America. Premier Research employs more than 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.


'/>"/>
SOURCE Premier Research Group plc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Premier Research Names Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety
2. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
3. Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons
4. Premier Research Names Patrick Melvin as Senior Director, Clinical Trial Management
5. Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research
6. Premier Research Appoints Global Head of Human Resources
7. Premier Research Appoints Melissa Jones as Vice President, International Business Development
8. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
9. Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO
10. Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... , ... February 21, 2017 ... ... Life -Sciences division, Treximo will pair its $200M operational capacity with its ... and project management in areas affecting quality and operational management. With ...
(Date:2/21/2017)... 21, 2017  Lexus, a returning partner of the Amgen ... and exclusive automobile partner of the men,s and women,s events for ... The 2017 Amgen Tour of California will ... of the best professional cycling teams in the world racing from ... four-day Amgen Breakaway from Heart Disease TM Women,s ...
(Date:2/21/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Bioplastics & ... 12.8% over the next decade to reach approximately $8.9 billion by ... and forecasts for all the given segments on global as well ...
(Date:2/20/2017)... 2017 This report analyzes the worldwide markets for ... Xylanase, Amylase, Cellulase, and Others. The report provides separate comprehensive ... Japan , Europe , ... and Rest of World. Read the full ... are provided for the period 2015 through 2022. Also, a ...
Breaking Biology Technology:
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
Breaking Biology News(10 mins):